"Ionizable lipid nanoparticles advance translation of mRNA-based vaccines & therapy” - Gairdner Week

Science & serendipity: lipid nanoparticles that enable COVID-19 mRNA vaccines - Gairdner LecturesПодробнее

"Ionizable lipid nanoparticles advance translation of mRNA-based vaccines & therapy” - Gairdner WeekПодробнее

2022 University of Manitoba Gairdner Lecture by Dr. Pieter CullisПодробнее

Novel Ionizable Lipid Library for Enabling Non-Viral Delivery – Dr. Lloyd JeffsПодробнее

eTheRNA’s mRNA Lipid Nanoparticles LNP Technology Developed for its Cancer Immunotherapy ProgramsПодробнее

Translating mRNA-Based Medicines from Concept to ClinicПодробнее

Polysarcosine-Functionalized Lipid Nanoparticles for Therapeutic mRNA DeliveryПодробнее

Accelerating Development of saRNA-Lipid Nanoparticle VaccinesПодробнее

Overcoming Key Challenges in Vaccine DevelopmentПодробнее

Nanomaterial Delivery Systems for mRNA Vaccines | RTCL.TVПодробнее

How Lipid Nanoparticles (LNPs) Dutifully Deliver mRNAПодробнее

Ionizable Lipids to Optimize RNA-LNP DeliveryПодробнее

What We Know About mRNA Vaccines Targeting BacteriaПодробнее

What are Lipid Nanoparticles (LNP)?Подробнее

Medical Uses of mRNA-based Directed Gene DeliveryПодробнее

The quest for next-generation lipid nanoparticles for cell-specific delivery of mRNAПодробнее

Building better vaccines with Dr. Bowen LiПодробнее

Challenges for mRNA LNP Formulation Development and ManufacturingПодробнее

"Nucleoside-Modified mRNA-LNP Therapeutics" - Dr. Drew Weissman, 2022 Gairdner Laureate LecturesПодробнее

Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid NanoparticlesПодробнее